Weekly Clinical Updates

Post–Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 | Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for COVID-19 | Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity | Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19 | Comparative Effectiveness of Combination Therapy with Nirmatrelvir–ritonavir and Remdesivir versus Monotherapy with Remdesivir | Postacute Sequelae of SARS-CoV-2 Infection | The Efficacy of Antivirals, Corticosteroids, and mAbs as Acute COVID Treatments

Proton Pump Inhibitors and Risk of COVID-19 Infection in Children | Long Covid The Answers

Effectiveness and Safety of Molnupiravir in the Intended-Use Population: An Observational Cohort Study | The Life-saving Benefit of Dexamethasone in Severe COVID-19 is Linked to a Reversal of Monocyte Dysregulation | EEG Signatures of Cognitive Decline after Mild SARS-CoV-2 Infection: An Age-dependent Study | Tissue-based T Cell Activation and Viral RNA Persist for Up to 2 Years after SARS-CoV-2 Infection

Human SARS-CoV-2 Challenge Uncovers Local and Systemic Response Dynamics | Cannabis, Tobacco Use, and COVID-19 Outcomes | Estimated Effectiveness of the BNT162b2 XBB Vaccine Against COVID-19 | Adjunctive Statin Therapy in Patients with Covid-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Nirmatrelvir and Ritonavir for Inpatients with Severe or Critical COVID-19 Beyond Five Days of Symptom Onset: A Propensity Score-matched, Multicenter, Retrospective Cohort Study | Faecal Microbiota Transplantation for Sleep Disturbance in Post-acute COVID-19 Syndrome | Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequela

Comparison of Two Methods for Sterilization of Filtering Facepiece Respirators Worn for Extended Periods During the COVID-19 Pandemic: An Experimental Laboratory Study | Real-world Effectiveness of Sotrovimab for the Treatment of SARS-CoV-2 Infection during Omicron BA.2 and BA.5 Subvariant Predominance: A Systematic Literature Review | Hospital Nurse Staffing Variation and COVID-19 Deaths: A Cross-sectional Study | Endothelial Dysfunction and Persistent Inflammation in Severe Post-COVID-19 Patients: Implications for Gas Exchange | Prevalence and Risk Factors of Cytomegalovirus Reactivation in Critically Ill Patients with COVID-19 Pneumonia | Epidemiologic Features of Recovery From SARS-CoV-2 Infection | Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection

Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016–2022 | Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024 | Neurodevelopmental Delay in Children Exposed to Maternal SARS-CoV-2 In-utero | COVID-19 is Associated with Early Emergence of Preeclampsia: Results from a Large Regional Collaborative | Effectiveness of Nirmatrelvir/ritonavir in Children and Adolescents Aged 12–17 Years Following SARS-CoV-2 Omicron Infection: A Target Trial Emulation | Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 Infection The STOP-PASC Randomized Clinical Trial